Content area

Abstract

Summary

The differential diagnosis of multiple sclerosis can present specific challenges in patients from Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific. In these areas, environmental factors, genetic background, and access to medical care can differ substantially from those in North America and western Europe, where multiple sclerosis is most common. Furthermore, multiple sclerosis diagnostic criteria have been developed primarily using data from North America and western Europe. Although some diagnoses mistaken for multiple sclerosis are common regardless of location, a comprehensive approach to the differential diagnosis of multiple sclerosis in Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific regions requires special consideration of diseases that are prevalent in those locations. A collaborative effort has therefore assessed global differences in multiple sclerosis differential diagnoses and proposed recommendations for evaluating patients with suspected multiple sclerosis in regions beyond North America and western Europe.

Details

Title
Differential diagnosis of suspected multiple sclerosis: global health considerations
Author
Correale, Jorge 1 ; Solomon, Andrew J 2 ; Cohen, Jeffrey A 3 ; Banwell, Brenda L 4 ; Gracia, Fernando 5 ; Gyang, Tirisham V 6 ; Fernando Hamuy Diaz de Bedoya 7 ; Harnegie, Mary P 8 ; Hemmer, Bernhard 9 ; Jacob, Anu 10 ; Ho Jin Kim 11 ; Marrie, Ruth Ann 12 ; Mateen, Farrah J 13 ; Newsome, Scott D 14 ; Pandit, Lekha 15 ; Prayoonwiwat, Naraporn 16 ; Sahraian, Mohammad A 17 ; Sato, Douglas K 18 ; Saylor, Deanna 19 ; Fu-Dong, Shi 20 ; Siva, Aksel 21 ; Tan, Kevin 22 ; Viswanathan, Shanthi 23 ; Wattjes, Mike P 24 ; Weinshenker, Brian 25 ; Yamout, Bassem 26 ; Fujihara, Kazuo 27 

 Department of Neurology, Fleni, Buenos Aires, Argentina; Institute of Biological Chemistry and Biophysics, CONICET/University of Buenos Aires, Buenos Aires, Argentina 
 Department of Neurological Sciences, Larner College of Medicine at the University of Vermont, Burlington, VT, USA 
 Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA 
 Division of Child Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA 
 Hospital Santo Tomás, Panama City, Panama; Universidad Interamericana de Panamá, School of Medicine, Panama City, Panama 
 Department of Neurology, The Ohio State University, Columbus, Ohio, USA 
 Universidad Nacional de Asunción, Centro Nacional de MS -Ministerio de Salud-Hospital IMT, Paraguay 
 Cleveland Clinic Libraries, Cleveland Clinic, Cleveland, Ohio, USA 
 Department of Neurology, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich Cluster for Systems Neurology, Munich, Germany 
10  Cleveland Clinic, Abu Dhabi, United Arab Emirates 
11  Department of Neurology, National Cancer Center, Goyang, South Korea 
12  Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada 
13  Department of Neurology, Massachusetts General Hospital, Harvard University, Boston, USA 
14  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA 
15  Center for Advanced Neurological Research, KS Hedge Medical Academy, Nitte University, Mangalore, India 
16  Division of Neurology, Department of Medicine and Siriraj Neuroimmunology Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand 
17  MS Research Center, Neuroscience Institute, Teheran University of Medical Sciences, Iran 
18  Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil 
19  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; University Teaching Hospital, Lusaka, Zambia 
20  Tianjin Medical University General Hospital, Tianjin, China; National Clinical Research Center for Neurological Disorders, Beijing Tiantan Hospital, Beijing, China 
21  Istanbul University Cerrahpasa, School of Medicine, Department of Neurology, Clinical Neuroimmunology Unit and MS Clinic, Istanbul, Türkiye 
22  Department of Neurology, National Neuroscience Institute, Singapore; Duke-NUS Medical School, Singapore 
23  Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia 
24  Department of Neuroradiology, Charité Berlin, Corporate Member of Freie Universität zu Berlin, Humboldt-Universität zu Berlin, Berlin, Germany 
25  Department of Neurology, University of Virginia, Charlottesville, VA, USA 
26  Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates 
27  Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine and Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan 
Pages
1035-1049
Section
Personal View
Publication year
2024
Publication date
Oct 2024
Publisher
Elsevier Limited
ISSN
14744422
e-ISSN
14744465
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3106628209
Copyright
©2024. Elsevier Ltd